Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 881.00
+103.00 (13.24%)
At close: Mar 27, 2026
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 29.98 billion as of March 27, 2026. Its market cap has increased by 88.65% in one year.
Market Cap
29.98B
Enterprise Value
28.08B
Revenue
968.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
881.00
Market Cap Chart
Since April 22, 2021, Stella Pharma's market cap has increased from 23.73B to 29.98B, an increase of 26.36%. That is a compound annual growth rate of 4.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 29.98B | 333.99% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | 23.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncolys BioPharma | 68.44B |
| Cuorips | 58.59B |
| Healios K.K. | 51.03B |
| Japan Tissue Engineering | 28.14B |
| AnGes | 23.74B |
| Renascience | 23.31B |
| RaQualia Pharma | 21.57B |
| StemRIM | 18.99B |